Establishment Labs Holdings (ESTA) Capital Expenditures Growth (3y) (2020 - 2026)
Establishment Labs Holdings (ESTA) Capital Expenditures Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 8.89% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 1.81% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 0.84% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 7.57% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 2.15% |
| 10 | Establishment Labs Holdings | 2.75 Bn | 2.68 Bn | 42.34 Mn | 6.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.97% |
| Dec 31, 2025 | -188.47% |
| Sep 30, 2025 | 87.35% |
| Jun 30, 2025 | 56.09% |
| Mar 31, 2025 | 14.22% |
| Dec 31, 2024 | -227.76% |
| Jun 30, 2024 | -258.50% |
| Mar 31, 2024 | 405.78% |
| Dec 31, 2023 | 114.52% |
| Sep 30, 2023 | -55.03% |
| Jun 30, 2023 | -45.99% |
| Mar 31, 2023 | 30.13% |
| Dec 31, 2022 | 33.79% |
| Sep 30, 2022 | 75.73% |
| Jun 30, 2022 | -0.33% |
| Mar 31, 2022 | 66.75% |
| Dec 31, 2021 | -29.88% |
| Jun 30, 2021 | -62.82% |
| Mar 31, 2021 | -27.37% |
| Dec 31, 2020 | -95.09% |